Explore the words cloud of the SAFE-N-MEDTECH project. It provides you a very rough idea of what is the project "SAFE-N-MEDTECH" about.
The following table provides information about the project.
TECNOLOGIA NAVARRA DE NANOPRODUCTOS SL
|Coordinator Country||Spain [ES]|
|Total cost||18˙344˙674 €|
|EC max contribution||14˙534˙365 € (79%)|
1. H2020-EU.2.1.3. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced materials)
2. H2020-EU.2.1.2. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies)
|Duration (year-month-day)||from 2019-04-01 to 2023-03-31|
Take a look of project's partnership.
|1||TECNOLOGIA NAVARRA DE NANOPRODUCTOS SL||ES (LOS ARCOS)||coordinator||350˙398.00|
|2||BIOKERALTY RESEARCH INSTITUTE AIE||ES (ARCAUTE ALAVA)||participant||1˙826˙750.00|
|3||CONSORCIO CENTRO DE INVESTIGACION BIOMEDICA EN RED M.P.||ES (MADRID)||participant||968˙657.00|
|4||TECHNISCHE UNIVERSITEIT EINDHOVEN||NL (EINDHOVEN)||participant||853˙000.00|
|5||THE PROVOST, FELLOWS, FOUNDATION SCHOLARS & THE OTHER MEMBERS OF BOARD OF THE COLLEGE OF THE HOLY & UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN||IE (DUBLIN)||participant||801˙885.00|
|6||SINTEF AS||NO (TRONDHEIM)||participant||799˙037.00|
|7||THE UNIVERSITY OF LIVERPOOL||UK (LIVERPOOL)||participant||732˙500.00|
|8||INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES||PT (LISBOA)||participant||714˙815.00|
|9||LABORATORIO IBERICO INTERNACIONAL DE NANOTECNOLOGIA||PT (BRAGA)||participant||669˙625.00|
|10||FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON - INSTITUT DE RECERCA||ES (BARCELONA)||participant||633˙517.00|
|11||STATENS ARBEIDSMILJOINSTITUTT||NO (OSLO)||participant||615˙000.00|
|12||STRYKER TRAUMA GMBH||DE (SCHONKIRCHEN)||participant||556˙087.00|
|13||FUNDACION TECNALIA RESEARCH & INNOVATION||ES (DERIO BIZKAIA)||participant||555˙643.00|
|14||GREENDECISION SRL||IT (VENEZIA)||participant||553˙875.00|
|15||VLAAMSE INSTELLING VOOR TECHNOLOGISCH ONDERZOEK N.V.||BE (MOL)||participant||512˙500.00|
|16||COUNCIL OF EUROPEAN BIOREGIONS||BE (BRUXELLES)||participant||496˙250.00|
|17||UNIVERSITA DEGLI STUDI DI PAVIA||IT (PAVIA)||participant||487˙500.00|
|18||RESONANT CIRCUITS LIMITED||UK (LONDON)||participant||464˙194.00|
|19||CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS||FR (PARIS)||participant||430˙250.00|
|20||MARACA INTERNATIONAL||BE (ROTSELAAR)||participant||413˙000.00|
|21||INSTITUTUL DE CHIMIE FIZICA ILIE MURGULESCU||RO (BUCHAREST)||participant||324˙250.00|
|22||DEPARTAMENTO DE SALUD GOBIERNO VASCO||ES (VITORIA-GASTEIZ)||participant||306˙880.00|
|23||KERALTY SAS||CO (BOGOTA)||participant||297˙500.00|
|24||EUROSCAN INTERNATIONAL NETWORK EV||DE (KOLN)||participant||171˙250.00|
|25||CHINA PHARMACEUTICAL UNIVERSITY||CN (NANJING)||participant||0.00|
|26||HUBEI GEDIAN HUMANWELL PHARMACEUTICAL CO., LTD||CN (EZHOU)||participant||0.00|
|27||NATIONAL CENTER FOR NANOSCIENCE AND TECHNOLOGY, CHINA||CN (BEIJING)||participant||0.00|
|28||STRYKER TRAUMA GMBH||DE (SCHONKIRCHEN)||participant||0.00|
Society and clinical practice pose a growing demand on novel biomaterials, ICT, micro and nanotechnologies for innovative medical devices and in vitro diagnostics (Medical Technologies-MTs). In addition to the challenge of time, the new technologies are subjected to other pressing factors such as qualification, regulation, cost, biocompatibility and the need to be applicable worldwide. In the most recent years it is obvious that nano-enabled MTs can be applied in nearly every medical area, with a major presence and increased importance in cancer, regenerative medicine, advanced therapies, neurology, cardiology, orthopaedics, and dentistry. On the other hand, any innovation in the Health sector has to be carefully assessed in terms of risk/benefit ratio. Nano-enabled MTs particularly require careful assessment, since they are complex products group and their technological assessments are still under development. This assessment will be a key pillar for the here proposed Open Innovation Test Bed (OITB) To address all the aforementioned challenges, the SAFE-N-MEDTECH consortium aims to bring a strong and competitive cooperation to compete in the market for a coordinated OITB for nano-enabled MTs. SAFE-N-MEDTECH will build an innovative open access platform to offer to companies and reference laboratories, the capabilities, knowhow, networks and services required for the development, testing, assessment, upscaling and market exploitation of nanotechnology-based Medical and Diagnosis Devices. This across the whole Life Cycle. This OITB will offer a multidisciplinary and market oriented innovation approach to SME´s, Healthcare providers and Industries for the translation to the market of MTs, based on a deep understanding and knowledge of the material-nanoproperties, their advance use and applications in MTs and other aspects involved in MTs safety (electric compatibility, electromagnetic properties, etc).
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SAFE-N-MEDTECH" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (email@example.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "SAFE-N-MEDTECH" are provided by the European Opendata Portal: CORDIS opendata.
MEFISTO - Meniscal functionalised scaffold to prevent knee Osteoarthritis onset after meniscectomyRead More
Recycling and Repurposing of Plastic Waste for Advanced 3D Printing ApplicationsRead More
A testing bed for the development of high-risk medical devicesRead More